What it is

MOTS-c is a mitochondrial-derived peptide (MDP) studied in metabolic regulation, exercise-capacity, and aging-adjacent laboratory models. Research links it to AMPK-related and folate-cycle–adjacent metabolic signaling.

Also known as

Mitochondrial open reading frame of the twelve S c · MDP

Overview

MOTS-c is a mitochondrial-derived peptide (MDP) studied in metabolic regulation, exercise-capacity, and aging-adjacent laboratory models. Research links it to AMPK-related and folate-cycle–adjacent metabolic signaling.

Interest centers on how mitochondrially encoded peptides influence nuclear gene programs and energy homeostasis in preclinical systems. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Metabolic and AMPK-adjacent signaling endpoints

• • Exercise-capacity and endurance markers in preclinical models

• • Insulin-sensitivity / glucose-handling readouts where studied

• • Aging and mitochondrial-stress research markers

• • Nuclear-mitochondrial communication measures in MDP designs

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early mitochondrial and energy-metabolism readouts; compound accumulating in model systems.

Week 3–4: Clearer redox, endurance, or cellular-energy markers in short preclinical windows.

Month 2–3: More pronounced metabolic and cytoprotection endpoints in extended designs.

Month 3–6: Sustained mitochondrial and aging-adjacent observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.